Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Abortion Drugs

Study finds 75% of women treated at ERs after taking abortion pills rated ‘severe or critical’

Women who visit emergency rooms after taking abortion pills are more likely to be seen for serious medical problems than their cohorts whose pregnancies end with surgical abortions or live births, according to newly released research.

A peer-reviewed study of Medicaid-eligible women by researchers at the pro-life Charlotte Lozier Institute found they were “significantly more likely to have a severe or critical acuity rating” within 30 days of using the two-drug abortion protocol than were other women seen at ERs.

That includes women who had recently given birth; undergone surgical abortions or visited the emergency room for any reason, a finding based on 2004-15 data in the 17 states where Medicaid covers abortion expenses.

Continue Reading at the Washington Times >>

Latest Posts

November 10, 2025 Veteran Journalist and Editor Terence P. Jeffrey Joins Charlotte Lozier Institute Veteran Journalist and Editor Terence P. Jeffrey Joins Charlotte Lozier Institute October 24, 2025 CLI Submits Comment Responding to Washington et al.’s Citizen Petition Requesting FDA Action on Mifepristone CLI Submits Comment Responding to Washington et al.’s Citizen Petition Requesting FDA Action on Mifepristone October 24, 2025 Testimony of CLI Associate Scholar Elizabeth Kirk, J.D. before the Pennsylvania House Judiciary Committee

You Might Also Be Interested In

CLI Submits Comment Responding to Washington et al.’s Citizen Petition Requesting FDA Action on Mifepristone

CLI Submits Comment Responding to Washington et al.’s Citizen Petition Requesting FDA Action on Mifepristone

charlotte-lozier-institute Charlotte Lozier Institute
October 24, 2025
Please login to bookmark Close

The Risks of Abortion Drugs

October 21, 2025
Please login to bookmark Close

Are drug-induced abortions without an in-person visit safe?

October 21, 2025
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image